The ERCHAM MK1 combines mouse and keyboard functions into a single unit. It features an optical sensor that enables ...
A new FDA-approved device helps people in Austin with spinal cord injuries improve hand strength, movement and daily ...
As a part of a study testing out a new type of implanted brain-computer interface (BCI), three rhesus monkeys controlled ...
Polaryx Therapeutics, Inc. (Nasdaq: PLYX), a clinical-stage biotechnology company developing disease-modifying therapies for rare pediatric LSDs, today announced that the U.S. Food and Drug ...
For three years, Dr. Jamal Eltaeb made excruciating choices. How would he find fuel to keep the hospital's lights on? As the ...
Along with its six-story height, the new JLG 600AJ+ mobile elevating work platform can extend 27 feet for going up and over ...
As published in The Lancet and presented at AAN, NIMBLE trial met its primary and key secondary endpoints at week 24, demonstrating potential best-in-class efficacy and convenience in gMG ...
Omdurman (Sudan), Apr 27 (AP) For three years, Dr Jamal Eltaeb made excruciating choices. Who should live and potentially die? Should he operate without the right medicines if it might save someone’s ...
QEMU 11 brings a new "nitro" accelerator for AWS Nitro Enclaves, more protection for confidential VMs, and extended support ...
These results underscore that fenebrutinib has potential as a high-efficacy oral treatment for RMS. Its unique mode of action may offer a differentiated profile by targeting dual drivers of MS within ...
John Ternus was the center of speculation as being the best and most likely choice for the next Apple CEO, and those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results